Search Results - Goedings, P

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    333 Phase I dose-escalation trial with the DNA-alkylating anti-HER2 antibody-drug conjugate SYD985

    333 Phase I dose-escalation trial with the DNA-alkylating anti-HER2 antibody-drug conjugate SYD985 by Van Herpen, C.M, Banerji, U, Mommers, E.C, Koper, N.P, Goedings, P, Lopez, J, Awada, A, Fiebrich, H.B, Aftimos, P.G

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer

    Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer by Aftimos, PG, van Herpen, CM, Mommers, EC, Koper, NP, Goedings, P, Oesterholt, M, Awada, A, Desar, IM, Lim, J, Dean, E, Rolfo, C, Macpherson, I, Banerji, U

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: